PTC THERAPEUTICS INC (PTCT)       46.25  +0.26 (+0.57%)

46.25  +0.26 (+0.57%)

US69366J2006 - Common Stock - After market: 46.25 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -1.53 -1.27 -0.26-20.74% Q2 2022 -2.13 -1.36 -0.77-56.73% Q1 2022 -1.78 -1.54 -0.24-15.81% Q4 2021 -2.03 -1.68 -0.35-20.96% Q3 2021 -1.89 -1.52 -0.37-24.74% Q2 2021 -1.68 -1.85 0.179.39% Q1 2021 -1.83 -1.54 -0.29-18.59% Q4 2020 -1.08 -0.95 -0.13-13.15%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -6.90 -7.43 7.07%Q4 2022 -1.43 -2.03 29.43%FY 2023 -4.59 -6.90 33.47%Q1 2023 -1.58 -1.78 11.00%Q2 2023 -1.71 -2.13 19.88%Q3 2023 -1.47 -1.53 3.68%Q4 2023 -1.13 -1.43 21.09%FY 2024 -2.69 -4.59 41.34%FY 2025 -3.75 -2.69 -39.10%FY 2026 -1.41 -3.75 62.31%FY 2027 1.07 -1.41 175.45%FY 2028 3.61 1.07 238.76%FY 2029 4.70 3.61 30.23%FY 2030 5.79 4.70 23.21%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 217.127M 190.64M 26.487M13.89% Q2 2022 165.526M 165.33M 196K0.12% Q1 2022 148.735M 150M -1.265M-0.84% Q4 2021 165.229M 153.85M 11.379M7.40% Q3 2021 138.743M 122.85M 15.893M12.94% Q2 2021 116.676M 112.71M 3.966M3.52% Q1 2021 117.9M 100.78M 17.12M16.99% Q4 2020 118.9M 113.58M 5.32M4.68%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 744.23M 538.593M 38.18%Q4 2022 204.79M 165.229M 23.94%FY 2023 881.99M 744.23M 18.51%Q1 2023 198.94M 148.735M 33.75%Q2 2023 192.77M 165.526M 16.46%Q3 2023 201.41M 217.127M -7.24%Q4 2023 230.21M 204.79M 12.41%FY 2024 988.74M 881.99M 12.10%FY 2025 1.021B 988.74M 3.26%FY 2026 1.212B 1.021B 18.71%FY 2027 1.28B 1.212B 5.61%FY 2028 1.412B 1.28B 10.31%FY 2029 1.475B 1.412B 4.46%FY 2030 1.337B 1.475B -9.36%